Bladder Cancer Trial, Recruiting (NCT05337397)

Bladder Cancer Trial, Recruiting NCT05337397 Sponsor: Jørgen Bjerggaard Jensen Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05337397 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Having at least one tumour that is larger than 1 cm in diameter
Having a papillary or non-solid type of bladder tumour
Having a history of low-grade, non-muscle-invasive bladder cancer (an early-stage form of bladder cancer that has not spread into the bladder muscle)
Being able to understand spoken and written information in Danish, Spanish, Czech, or French
Having signed a consent form to take part in the trial

Who may not be able to join:

Having a tumour larger than 3 cm in diameter
Having a tumour located in the prostatic urethra (the part of the urine channel that passes through the prostate gland)
Having a history of a more aggressive type of bladder cancer — such as carcinoma in situ (CIS), high-grade bladder cancer, or muscle-invasive bladder cancer — unless a later low-grade recurrence has since occurred
Having a positive urine cell test (cytology) within the past 3 months (confirm with trial site, as this test may not be required for all patients)
Being pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jørgen B Jensen, Professor, MD, Skejby University Hospital: Aarhus Universitetshospital

Phone: +4578452617

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05337397

Sponsor: Jørgen Bjerggaard Jensen

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: +4578452617

More information: https://clinicaltrials.gov/study/NCT05337397

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Having at least one tumour that is larger than 1 cm in diameter
Having a papillary or non-solid type of bladder tumour
Having a history of low-grade, non-muscle-invasive bladder cancer (an early-stage form of bladder cancer that has not spread into the bladder muscle)
Being able to understand spoken and written information in Danish, Spanish, Czech, or French
Having signed a consent form to take part in the trial

Who may not be able to join:

Having a tumour larger than 3 cm in diameter
Having a tumour located in the prostatic urethra (the part of the urine channel that passes through the prostate gland)
Having a history of a more aggressive type of bladder cancer — such as carcinoma in situ (CIS), high-grade bladder cancer, or muscle-invasive bladder cancer — unless a later low-grade recurrence has since occurred
Having a positive urine cell test (cytology) within the past 3 months (confirm with trial site, as this test may not be required for all patients)
Being pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jørgen Bjerggaard Jensen

Registry

ClinicalTrials.gov

Start date

1 May 2022

Est. completion

1 April 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Succesful laser ablations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov